The APOE gene is the only clinically accepted genetic risk factor for late onset Alzheimer’s disease. Every person inherits two copies (one from each parent) of the APOE gene. Each copy of the APOE gene exists in one of three forms, or alleles: ε2, ε3, or ε4. Therefore, every individual possesses one of the following six possible APOE combinations:


The APOE gene provides instructions for making a protein called apolipoprotein E. This protein combines with fats (lipids) in the body and is known as a lipoprotein. Lipoproteins are responsible for packaging cholesterol and other fats, carrying them through the bloodstream, and delivering them to the appropriate locations in the body for processing and use.1
The brains of people with Alzheimer’s disease have increased amounts of two abnormal structures:
Plaques and tangles usually develop as a person ages, beginning in areas devoted to learning and memory and gradually spreading to other areas. They develop much more, however, in those with Alzheimer’s disease. Though researchers have yet to identify the precise mechanism by which the APOE ε4 form affects plaque and tangle development, they have discovered a definite association between the presence of the ε4 form and an increase in plaques and tangles.
1Content from Genetics Home Reference Public Information from the U.S. National Institutes of Health